title: [The role of thrombin activatable fibrinolysis inhibitors (TAFI) in coronary artery disease].
authors.affiliation: Klinika Kardiochirurgii AM w Białymstoku. lispiotr@poczta.onet.pl
authors.forename: Piotr
authors.initials: P
authors.lastname: Lisowski
authors.forename: Jolanta
authors.initials: J
authors.lastname: Małyszko
authors.forename: Ryszard
authors.initials: R
authors.lastname: Jackowski
authors.forename: Michał
authors.initials: M
authors.lastname: Myśliwiec
authors.forename: Anna
authors.initials: A
authors.lastname: Lisowska
authors.forename: Tomasz
authors.initials: T
authors.lastname: Łapiński
authors.forename: Krystyna
authors.initials: K
authors.lastname: Pawlak
authors.forename: Tomasz
authors.initials: T
authors.lastname: Hirnle
mesh_terms: D000818:Animals; D025901:Carboxypeptidase B2 / Q000378:metabolism*; D003324:Coronary Artery Disease / Q000201:enzymology* / Q000473:pathology / Q000503:physiopathology*; D004730:Endothelium, Vascular / Q000473:pathology; D006801:Humans; D012307:Risk Factors
chemical_list: D025901:Carboxypeptidase B2